needed effects
telaprevir
unwanted side effects
medical attention
telaprevir side effects
medical attention
body
medicine
side effects
health care professional
side effects
following side effects
telaprevir
combination with peginterferon alfa
ribavirin
prescribing information for peginterferon alfa
ribavirin
associated side effects
serious side effects
patients
receiving telaprevir combination therapy
none of the patients
receiving peginterferon alfa
ribavirin
serious side effects
skin disorders
rash
pruritus
anemia
telaprevir
side effects
patients
side effects
discontinuation
anemia
fatigue
pruritus
nausea
vomiting
following side effects
patients
receiving telaprevir combination therapy with an incidence at least greater than those
receiving peginterferon alfa
ribavirin
rash
first weeks
time during telaprevir combination therapy
rash events
discontinuation of telaprevir
telaprevir combination therapy
patients
severe rash
prominent eczematous component
fatal cases
patients with progressive rash
systemic symptoms
telaprevir combination therapy after serious skin reaction
presenting signs of dress
rash
fever
facial edema
evidence of internal organ involvement
hepatitis
nephritis
eosinophilia
presenting signs of sjs
fever
target lesions
mucosal erosions
ulcerations
conjunctivae
lips
rash
grades
pruritus
severe rash
generalized rash
rash with vesicles
ulcerations
stevens-johnson syndrome
serious skin reactions
including drug reaction with eosinophilia
systemic symptoms
dress
stevens-johnson syndrome
sjs
frequency
nonfatal serious skin reactions
including sjs
dress
toxic epidermal necrolysis
dry skinpostmarketing reports
toxic epidermal necrolysis
erythema multiforme
addition of telaprevir
peginterferon alfa
ribavirin
further decrease in hemoglobin levels
decreased hemoglobin levels
first weeks of therapy
lowest values
end of telaprevir dosing
telaprevir dosing
hemoglobin levels
levels
peginterferon alfa
ribavirin
g/dl
g/dl
clinical trials
time
onset of hemoglobin levels g/dl
telaprevir combination therapy
days
range
days
therapy with peginterferon alfa
ribavirin
days
days
patients
receiving telaprevir combination therapy
ribavirin dose modification
reduction
interruption
discontinuation
anemia
blood transfusion
discontinued telaprevir
discontinued telaprevir combination therapy
patients
receiving peginterferon alfa
ribavirin
ribavirin dose modification
anemia
blood transfusion
discontinued therapy
anemia
requiring ribavirin dose reduction
blood transfusion
erythropoiesis stimulating agent
days after initiation of telaprevir combination therapy
decreased total white blood cell
absolute neutrophil
absolute lymphocyte
platelet counts
peginterferon alfa
decreased total white cell counts
mm
patients
peginterferon alfa
decreased absolute neutrophil counts
mm
patients
peginterferon alfa
ribavirin
decreased platelet counts
grades
mm
patients
peginterferon alfa
ribavirin
anemia
mean platelet counts
grades
hemoglobin levels
g/dl
g/dl
lymphocyte counts
mm
absolute neutrophil counts
mm
decreased total white cell counts
mm
mean platelet counts
mm
elevated uric acid levels
uric acid level shifts from baseline
mg/dl
greater uncommon
gout/gouty arthritis
frequency
nutrition disorders
nausea
diarrhea
vomiting
hemorrhoids
anorectal discomfort
anal pruritus frequency
rectal burning
anorexia
abdominal discomfort
constipation
anorectal side effects
patients
majority of anorectal side effects
hemorrhoids
anorectal discomfort
anal pruritus
rectal burning
moderate severity
discontinuation of therapy
completion of telaprevir dosing
fatigue frequency
pyrexia
influenza-like illness
infections
infestations
bilirubin levels
weeks of telaprevir
baseline levels between weeks
elevated bilirubin
grades
times uln
patients
peginterferon alfa
ribavirin
elevated bilirubin
grades
elevated bilirubin
times uln
dysgeusia frequency
headache
frequency
depression
insomnia
frequency
myalgia
musculoskeletal disorders
postmarketing reports
prerenal azotemia
acute renal insufficiency/failure
uric acid nephropathy
frequency
ocular events
side effects of telaprevir
fda
healthcare professional for medical advice
black, tarry stools
bleeding gums
blood in the urine
stools
chills
cough
fever
joint pain
stiffness
swelling
side
stomach pain
difficult urination
pale skin
red spots on the skin
rash
shortness of breath
sore throat
swelling of the feet
lower legs
troubled breathing with exertion
ulcers
sores
white spots in the mouth
unusual bleeding
bruising
unusual tiredness
weakness
blistering
peeling
loosening of the skin
cloudy urine
dark urine
diarrhea
difficulty with breathing
drowsiness
general tiredness
weakness
headache
itching
muscle pain
light-colored stools
nausea or vomiting
red skin lesions
purple center
red, irritated eyes
swelling
puffiness of the face
unusual weight gain
stomach pain
yellow eyes
skin
bleeding with stools
uncomfortable swelling around the anus